Ajinomoto Co., Inc. (AJINY)
OTCMKTS
· Delayed Price · Currency is USD
26.99
-0.23 (-0.84%)
Jul 3, 2025, 12:58 PM EDT
Ajinomoto Co. Revenue
In the fiscal year ending March 31, 2025, Ajinomoto Co. had annual revenue of 1.53T JPY with 6.35% growth. Ajinomoto Co. had revenue of 379.52B in the quarter ending March 31, 2025, with 2.14% growth.
Revenue
1,530.56B JPY
Revenue Growth
+6.35%
P/S Ratio
2.56
Revenue / Employee
43.91M JPY
Employees
34,860
Market Cap
26.14B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 1,530.56B | 91.33B | 6.35% |
Mar 31, 2024 | 1,439.23B | 80.12B | 5.89% |
Mar 31, 2023 | 1,359.12B | 209.75B | 18.25% |
Mar 31, 2022 | 1,149.37B | 77.92B | 7.27% |
Mar 31, 2021 | 1,071.45B | -28.59B | -2.60% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cordyceps Sunshine Biotech Holdings | 1.25M |
Cuisine Solutions | 80.48M |
Armanino Foods of Distinction | 69.40M |
South Dakota Soybean Processors, LLC | 524.07M |
ESG Inc. | 11.89M |
Pyxus International | 2.48B |
Crimson Wine Group | 71.52M |
Hi-Great Group Holding Company | 69.04K |
Ajinomoto Co. News
- 7 weeks ago - Ajinomoto Co., Inc. (AJINY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Ajinomoto Co GAAP EPS of ¥69.77 - Seeking Alpha
- 2 months ago - Part of $1 Billion Investment Strategy, PCI Pharma Services Completes Acquisition of Ajinomoto Althea, Enhancing US Drug Product Manufacturing for Aseptic Filling of Prefilled Syringes & Cartridges - Business Wire
- 2 months ago - L-Phenylalanine Market Insights and Forecast to 2030 Featuring Profiles (SWOT, Sales, Prices) of Key Players - Evonik, Ajinomoto, Daesang, and Wuxi Jinghai Amino Acid Co. - GlobeNewsWire
- 2 months ago - L-Alanyl-L-Glutamine Market Report 2025: Includes Insights Into the Sales, Revenue, Price, Gross Margin & SWOT of Kyowa Hakko, Ajinomoto, and Evonik - GlobeNewsWire
- 2 months ago - PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea - Business Wire
- 5 months ago - Q3 2025 Ajinomoto Co Inc Earnings Presentation Transcript - GuruFocus
- 5 months ago - Ajinomoto GAAP EPS of ¥163.08, revenue of ¥1151.04B; reaffirms FY outlook - Seeking Alpha